CAPPED BONUSZERTIFIKAT - STRYKER CORP. Share Price

Certificat

DE000PC5RUB7

Real-time Boerse Frankfurt Warrants 13:20:33 27/06/2024 BST
250.2 EUR -0.35% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month+2.29%
1 month+2.65%
Date Price Change
27/06/24 250.2 -0.35%
26/06/24 251 +0.48%
25/06/24 249.8 +0.15%
24/06/24 249.4 -0.37%
21/06/24 250.4 -0.10%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 01:20 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RUB
ISINDE000PC5RUB7
Date issued 27/02/2024
Strike 300 $
Maturity 19/12/2025 (540 Days)
Parity 1 : 1
Emission price 239.5
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 251.3
Lowest since issue 238
Spread 0.6
Spread %0.24%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.5 USD
Average target price
372.9 USD
Spread / Average Target
+9.52%
Consensus